BioPharma Credit PLC
BPCP.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £6 | £86 | £121 | £95 |
| Short-Term Investments | £0 | £49 | £0 | £0 |
| Receivables | £32 | £20 | £20 | £10 |
| Inventory | £0 | £0 | -£0 | £0 |
| Other Curr. Assets | £0 | £0 | £0 | £0 |
| Total Curr. Assets | £37 | £155 | £140 | £105 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £1,162 | £1,201 | £1,224 | £1,266 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £1,162 | £1,201 | £1,224 | £1,266 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £1,200 | £1,357 | £1,364 | £1,371 |
| Liabilities | – | – | – | – |
| Payables | £1 | £0 | £0 | £2 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £17 | £16 | £26 | £4 |
| Total Curr. Liab. | £18 | £16 | £26 | £6 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £1 |
| Total NC Liab. | £0 | £0 | £0 | £1 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £18 | £16 | £27 | £7 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £14 | £14 | £14 | £14 |
| Retained Earnings | £561 | £720 | £717 | £743 |
| AOCI | £0 | £0 | £0 | £0 |
| Other Equity | £607 | £607 | £607 | £607 |
| Total Equity | £1,182 | £1,341 | £1,337 | £1,364 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £1,200 | £1,357 | £1,364 | £1,371 |
| Net Debt | -£6 | -£86 | -£121 | -£95 |